Cargando…

Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma

Aurora B kinase has emerged as a key regulator of mitosis and deregulation of Aurora B activity is closely related to the development and progression of human cancers. In the present study, we found that Aurora B is overexpressed in human esophageal squamous cell carcinoma (ESCC), high levels of Aur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xinfang, Liang, Qi, Liu, Wenbin, Zhou, Li, Li, Wei, Liu, Haidan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832566/ https://www.ncbi.nlm.nih.gov/pubmed/29129699 http://dx.doi.org/10.1016/j.ebiom.2017.10.030

Ejemplares similares

Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
por: Li, Ming, et al.
Publicado: (2017)

Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma
por: Baba, Yuh, et al.
Publicado: (2017)

Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization
por: Gao, Feng, et al.
Publicado: (2020)

Repression of Noxa by Bmi1 contributes to deguelin‐induced apoptosis in non‐small cell lung cancer cells
por: Li, Wei, et al.
Publicado: (2018)

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
por: Bao, Zhuo, et al.
Publicado: (2022)

Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors
por: Cannon, Claire M, et al.
Publicado: (2013)

Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance
por: Li, Ming, et al.
Publicado: (2021)

Akt inhibitor deguelin aggravates inflammation and fibrosis in myocarditis
por: Li, Shanshan, et al.
Publicado: (2019)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
por: Chen, Xiaojie, et al.
Publicado: (2022)

Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma
por: Baba, Yuh, et al.
Publicado: (2017)

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
por: Yu, Xinfang, et al.
Publicado: (2017)

Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells
por: Yang, Yan-li, et al.
Publicado: (2013)

Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015)

P21-Activated Kinase 7 Mediates Cisplatin-Resistance of Esophageal Squamous Carcinoma Cells with Aurora-A Overexpression
por: He, Shun, et al.
Publicado: (2014)

Stereocontrolled semi-syntheses of deguelin and tephrosin
por: Russell, David A., et al.
Publicado: (2017)

BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2011)

Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma
por: Mizumoto, Ayaka, et al.
Publicado: (2019)

Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1
por: Yan, Bing, et al.
Publicado: (2016)

Search for Potent and Selective Aurora A Inhibitors Based on General Ser/Thr Kinase Pharmacophore Model
por: Vasilevich, Natalya I., et al.
Publicado: (2016)

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity
por: Zhou, Yuanfeng, et al.
Publicado: (2018)

Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012)

Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma
por: Tamotsu, Kiyokazu, et al.
Publicado: (2015)

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2015)

Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
por: Liu, Wenbin, et al.
Publicado: (2019)

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
por: Xu, Xiao Dong, et al.
Publicado: (2017)

Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma
por: Lu, Heng, et al.
Publicado: (2022)

Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells
por: Failes, Timothy W., et al.
Publicado: (2012)

Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti-aspergillus fumigatus dual efficacies in vitro
por: He, Yuhua, et al.
Publicado: (2021)

Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma
por: Shi, Ke, et al.
Publicado: (2021)

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells
por: LI, ZHENGGUANG, et al.
Publicado: (2014)

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
por: Gully, Christopher P, et al.
Publicado: (2010)

A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
por: de Groot, Christian O., et al.
Publicado: (2015)

Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor
por: Tran, Thu-Hien Thi, et al.
Publicado: (2022)

Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42
por: Su, Lingyu, et al.
Publicado: (2020)

Oxymatrine inhibits non–small cell lung cancer via suppression of EGFR signaling pathway
por: Li, Wei, et al.
Publicado: (2017)

Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma
por: Liu, Fuchen, et al.
Publicado: (2017)

Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway
por: Li, Lin, et al.
Publicado: (2023)

Aurora kinases in ovarian cancer
por: Pérez-Fidalgo, J Alejandro, et al.
Publicado: (2020)

Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors
por: Jadhav, Mrunal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_82f836bp0l8j6bjg72c95pteei